2015
DOI: 10.1016/j.cca.2015.09.031
|View full text |Cite|
|
Sign up to set email alerts
|

Procalcitonin and community-acquired pneumonia (CAP) in children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
20
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(22 citation statements)
references
References 27 publications
2
20
0
Order By: Relevance
“…[121][122][123] The reported performance characteristics of procalcitonin versus CRP vary, with no clear evidence that either is superior. 121 124 BTS guidelines recommend against the use of acute phase reactants for distinguishing between bacterial and viral pneumonia, 28 whereas IDSA guidelines recommend that they are not used as the only distinguishing determinant.…”
Section: Host Biomarkers For Distinguishing Between Bacterial and Virmentioning
confidence: 99%
“…[121][122][123] The reported performance characteristics of procalcitonin versus CRP vary, with no clear evidence that either is superior. 121 124 BTS guidelines recommend against the use of acute phase reactants for distinguishing between bacterial and viral pneumonia, 28 whereas IDSA guidelines recommend that they are not used as the only distinguishing determinant.…”
Section: Host Biomarkers For Distinguishing Between Bacterial and Virmentioning
confidence: 99%
“…In the last decades, a role of hypovitaminosis D has emerged [3]. Since the discovery of vitamin D immunomodulatory function, vitamin D has been proposed as a serum biomarker in several clinical conditions, including neurodegenerative disorders, along with inflammatory and cardiovascular markers [4][5][6][7][8][9][10][11][12][13][14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…Pneumonia is one of the most common infectious causes of death in children worldwide (11). However, early diagnosis and intervention can effectively reduce the morbidity and mortality rates (12) LRTI in children requires the use of laboratory tests either for detecting the etiology agent, for planning the treatment, or for predicting prognosis of the disease (13).…”
Section: Discussionmentioning
confidence: 99%